Chalmers Ventures head of startups Stina Linge will leave on September 2 to head up Lipidor's animal health products unit Emollivet.
Stina Linge is set to vacate Chalmers Ventures, the investment and incubator arm of Chalmers University of Technology, after almost five years.
Linge will depart on September 2, 2020 to become chief executive of Emollivet, an animal health-focused subsidiary of skincare and dermatology product firm Lipidor.
Her arrival coincides with plans to extend Emollivet’s animal care pipeline, Akvano, and a new share issue to be presented at Lipidor’s extraordinary general meeting.
Linge has been with Chalmers Ventures…
